Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BTN3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBXO38 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OARD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAFB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF775 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGTA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTENP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGCX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDM6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC94 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NADK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAU2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THOP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2I - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on